The BEAUTIFUL study:: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population

被引：43

作者：

Fox, Kim ^{[1
]}

Recena, J. Balaguer ^{[1
]}

Garcia-Aranda, V. Lopez ^{[1
]}

Valderrama, J. Caparros ^{[1
]}

Alonso, L. F. Iglesias ^{[1
]}

Calvar, A. San Roman ^{[1
]}

Aviles, F. Fernandez ^{[1
]}

Villa, F. Perez ^{[1
]}

Cortada, J. Bruguera ^{[1
]}

Alvarez, R. Fernandez ^{[1
]}

Peiro, F. Noriega ^{[1
]}

Iglesias, F. Calvo ^{[1
]}

Toral, B. Sevilla ^{[1
]}

Bescos, L. Lopez ^{[1
]}

De Burgos, F. Garcia ^{[1
]}

Casado, R. Sola ^{[1
]}

Galve, E. ^{[1
]}

Garcia, G. Casares ^{[1
]}

Dellborg, M. ^{[1
]}

Herlitz, J. ^{[1
]}

Ullman, B. ^{[1
]}

Blomgren, J. ^{[1
]}

Bandh, S. ^{[1
]}

Oehlin, H. ^{[1
]}

Dubach, P. ^{[1
]}

Gallino, A. ^{[1
]}

Hess, O. ^{[1
]}

Moccetti, T. ^{[1
]}

Eeckhout, E. ^{[1
]}

Vontobel, H. ^{[1
]}

Delabays, A. ^{[1
]}

Erol, K. ^{[1
]}

Kozan, O. ^{[1
]}

Mutlu, B. ^{[1
]}

Ergene, O. ^{[1
]}

Acarturk, E. ^{[1
]}

Yilmaz, H. ^{[1
]}

Ural, D. ^{[1
]}

Parkhomenko, O. ^{[1
]}

Polyvoda, S. ^{[1
]}

Dyadyk, A. ^{[1
]}

Vatutin, M. ^{[1
]}

Karpenko, O. ^{[1
]}

Kubyshkin, V. ^{[1
]}

Rudenko, L. ^{[1
]}

Putintsev, V. ^{[1
]}

Krayz, I. ^{[1
]}

Kovalsky, I. ^{[1
]}

Rudyk, Y. ^{[1
]}

Yurlov, V. ^{[1
]}

机构：

[1] Royal Brompton Hosp, London SW3 6NP, England

来源：

CARDIOLOGY | 2008年 / 110卷 / 04期

关键词：

coronary artery disease; heart rate; ivabradine; left ventricular dysfunction; mortality;

D O I：

10.1159/000112412

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: Ivabradine is a selective heart rate-lowering agent that acts by inhibiting the pacemaker current I-f in sinoatrial node cells. Patients with coronary artery disease and left ventricular dysfunction are at high risk of death and cardiac events, and the BEAUTIFUL study was designed to evaluate the effects of ivabradine on outcome in such patients receiving optimal medical therapy. This report describes the study population at baseline. Methods: BEAUTIFUL is an international, multicentre, randomized, double-blind trial to compare ivabradine with placebo in reducing mortality and cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction (ejection fraction < 40%). Results: A total of 10,917 patients were randomized. At baseline, their mean age was 65 years, 83% were male, 98% Caucasian, 88% had previous myocardial infarction, 37% had diabetes, and 40% had metabolic syndrome. Mean ejection fraction was 32% and resting heart rate was 71.6 bpm. Concomitant medications included beta-blockers (87%), renin-angiotensin system agents (89%), antithrombotic agents (94%), and lipid-lowering agents (76%). Conclusions: Main results from BEAUTIFUL are expected in 2008, and should show whether ivabradine, on top of optimal medical treatment, reduces mortality and cardiovascular events in this population of high-risk patients. Copyright (c) 2007 S. Karger AG, Basel.

引用

页码：271 / 282

页数：12

共 69 条

[1] SUBSETS OF AMBULATORY MYOCARDIAL-ISCHEMIA BASED ON HEART-RATE ACTIVITY - CIRCADIAN DISTRIBUTION AND RESPONSE TO ANTIISCHEMIC MEDICATION
ANDREWS, TC
FENTON, T
TOYOSAKI, N
GLASSER, SP
YOUNG, PM
MACCALLUM, G
GIBSON, RS
SHOOK, TL
STONE, PH
[J]. CIRCULATION, 1993, 88 (01) : 92 - 100
[2] ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - Summary article
不详
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) : 1116 - 1143
[3] Optimal medical therapy with or without PCI for stable coronary disease
Boden, William E.
O'Rourke, Robert A.
Teo, Koon K.
Hartigan, Pamela M.
Maron, David J.
Kostuk, William J.
Knudtson, Merril
Dada, Marcin
Casperson, Paul
Harris, Crystal L.
Chaitman, Bernard R.
Shaw, Leslee
Gosselin, Gilbert
Nawaz, Shah
Title, Lawrence M.
Gau, Gerald
Blaustein, Alvin S.
Booth, David C.
Bates, Eric R.
Spertus, John A.
Berman, Daniel S.
Mancini, G. B. John
Weintraub, William S.
Boden, W.
O'Rourke, R.
Teo, K.
Hartigan, P.
Weintraub, W.
Maron, D.
Mancini, J.
Weintraub, W.
Boden, W.
O'Rourke, R.
Teo, K.
Hartigan, P.
Knudtson, M.
Maron, D.
Bates, E.
Blaustein, A.
Booth, D.
Carere, R.
Ellis, S.
Gosselin, G.
Gau, G.
Jacobs, A.
King, S., III
Kostuk, W.
Harris, C.
Spertus, J.
Peduzzi, P.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) : 1503 - 1516
[4] Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells
Bois, P
Bescond, J
Renaudon, B
Lenfant, J
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (04) : 1051 - 1057
[5] FACTORS THAT DETERMINE THE OCCURRENCE OF ARRHYTHMIAS DURING ACUTE MYOCARDIAL-ISCHEMIA
BOLLI, R
FISHER, DJ
ENTMAN, ML
[J]. AMERICAN HEART JOURNAL, 1986, 111 (02) : 261 - 270
[6] Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial
Borer, JS
Fox, K
Jaillon, P
Lerebours, G
[J]. CIRCULATION, 2003, 107 (06) : 817 - 823
[7] CHANGES IN DIASTOLIC TIME WITH VARIOUS PHARMACOLOGIC AGENTS - IMPLICATION FOR MYOCARDIAL PERFUSION
BOUDOULAS, H
RITTGERS, SE
LEWIS, RP
LEIER, CV
WEISSLER, AM
[J]. CIRCULATION, 1979, 60 (01) : 164 - 169
[8] Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[9] Current-dependent block of rabbit sino-atrial node If channels by ivabradine
Bucchi, A
Baruscotti, M
DiFrancesco, D
[J]. JOURNAL OF GENERAL PHYSIOLOGY, 2002, 120 (01) : 1 - 13
[10] Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels
Bucchi, A
Tognati, A
Milanesi, R
Baruscotti, M
DiFrancesco, D
[J]. JOURNAL OF PHYSIOLOGY-LONDON, 2006, 572 (02): : 335 - 346

← 1 2 3 4 5 6 7 →